(COVID-19),and as a consequence,develop more severe form of disease.This is partly due to a systemic inflammatory state and pro thrombotic milieu seen in metabolic syndrome.In this review,we attempt to explore the pathogenetic links between insulin resistance and COVID-19 disease severity....
In contrast to individuals without diabetes, COVID-19 infection in those with diabetes is associated with an increased risk of adverse outcomes such as more severe disease, pneumonia, ICU admissions, need for assisted ventilation and mortality. It is, however, not clear how much of this excess ...
The virus that causes COVID-19 first attacks cells in therespiratory system, often leading to an inflammation of the lungs that puts people at risk of contracting pneumonia. But the virus' impact has also been felt in other systems of the body. "COVID-19's effects extend far beyond the ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape'sCoronavirus Resource Center. SARS-CoV-2 infection was associated with an increased risk for diabetes among youth, whereas other acuterespiratory infectionswere not, new data from the US Centers for Disease Control and Prevent...
Two recent studies suggest the virus that causes COVID-19 can target and damage the body’s cells that produce insulin, a vital hormone that regulates blood sugar in the body.
of severe disease outcomes. The current large global burden of disease due to both COVID-19 and diabetes is likely to be a significant public health concern worldwide, making it crucial to quantify the impact of diabetes on the pandemic and develop management strategies to mitigate its risk. ...
近日, Journal of Diabetes 杂志联合 主编Zachary Bloomgarden教授发表述评,标题为“Diabetes and COVID-19”。 目前,中国和世界面临着前所未有的高传染性病毒疾病的巨大挑战。每年,数百万人(占世界人口的5%-15%)感染流感,造成30万至60万人因呼吸系统疾病额外死亡。仅在中国,最近的估计显示每年与流感有关的死亡率超...
Investigators in the Smidt Heart Institute at Cedars-Sinai have confirmed that people who have had COVID-19 have an increased risk for new-onset diabetes—the most significant contributor to cardiovascular disease.
Hospital management of hyperglycemia in the context of COVID-19: evidence-based clinical considerations The COVID-19 pandemic led to an unprecedented crisis, and early on, it has been shown that diabetes is an important risk factor for complications and mortality in infected patients, as demonstrat...
This episode focuses on diabetes and COVID-19. Questions are answered regarding the risk for COVID-19 among patients with diabetes, medication concerns in those who test positive for the virus, and the importance of self-monitoring of glucose levels among patients with type 1 and type 2 diabet...